Vanda Pharmaceuticals
(NASDAQ) VNDA
Vanda Pharmaceuticals Financials at a Glance
Market Cap
$393.07M
Revenue (TTM)
$216.10M
Net Income (TTM)
$220.47M
EPS (TTM)
$-3.74
P/E Ratio
-1.78
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$6.77
Volume
3,997
Open
$6.73
Price
$6.77
Volume
3,997
Open
$6.73
Previous Close
$6.65
Daily Range
$6.73 - $6.88
52-Week Range
$3.81 - $9.94
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$6.77
Volume
3,997
Open
$6.73
Previous Close
$6.65
Daily Range
$6.73 - $6.88
52-Week Range
$3.81 - $9.94
VNDA News
1 Pharma Stock to Avoid at All Costs
VNDA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vanda Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
533
CEO
Mihael Hristos Polymeropoulos, MD
Website
www.vandapharma.comHeadquarters
Washington, DC 20037, US
VNDA Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
-72%
Net Income Margin
-1%
Return on Equity
-51%
Return on Capital
-45%
Return on Assets
-45%
Earnings Yield
-56.18%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$393.07M
Shares Outstanding
59.11M
Volume
4.00K
Short Interest
0.00%
Avg. Volume
3.03M
Financials (TTM)
Gross Profit
$203.06M
Operating Income
$151.17M
EBITDA
$139.25M
Operating Cash Flow
$109.44M
Capital Expenditure
$998.00K
Free Cash Flow
$110.44M
Cash & ST Invst.
$263.85M
Total Debt
$12.62M
Vanda Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$57.22M
+7.6%
Gross Profit
$53.38M
+5.5%
Gross Margin
93.30%
N/A
Market Cap
$393.07M
N/A
Market Cap/Employee
$1.07M
N/A
Employees
368
N/A
Net Income
$141.19M
-2774.3%
EBITDA
$34.49M
-315.2%
Quarterly Fundamentals
Net Cash
$251.22M
-30.7%
Accounts Receivable
$54.58M
+15.9%
Inventory
$1.85M
+7.3%
Long Term Debt
$7.07M
-12.6%
Short Term Debt
$5.55M
+30.1%
Return on Assets
-45.09%
N/A
Return on Invested Capital
-45.00%
N/A
Free Cash Flow
$29.52M
-1353.4%
Operating Cash Flow
$29.42M
-1519.0%